Vertex Pharma (VRTX) Tops Q3 EPS by 7c
Tweet
Share
E-mail
Get Alerts VRTX Hot Sheet
Price: $491.34 --0%
Revenue Growth %: +8.4%
Financial Fact:
Loss before provision for income taxes: -39.03M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Revenue Growth %: +8.4%
Financial Fact:
Loss before provision for income taxes: -39.03M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q3 EPS of $1.09, $0.07 better than the analyst estimate of $1.02. Revenue for the quarter came in at $783.9 million versus the consensus estimate of $790.91 million.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley continues to recommend exposure to the broadening theme
- SilverCape cuts acquisition bid for PetMed Express to $3 per share
- Optical Cable Corporation added to Russell Microcap Index
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
